Intracranial Arterial Stenting

Introduction

If you or a family member has been told that an artery deep inside the brain is severely narrowed, you are likely weighing some difficult information. The narrowing — called intracranial arterial stenosis — raises the risk of stroke, and treatment decisions can feel urgent and complex. One of the options that may have come up in your conversations with a neurologist or interventional neuroradiologist is intracranial arterial stenting.

This article explains what intracranial arterial stenting is, when it is considered, what alternatives exist, how the procedure is performed, what recovery looks like, and what long-term care typically involves. It is written for patients and families who already have a diagnosis of intracranial arterial narrowing and are now thinking through next steps with their treatment team.

Intracranial arterial stenting is a specialised procedure with a narrow set of indications. The decision to proceed is never automatic. Major stroke societies emphasise that medical therapy is the first treatment for most patients with this condition, and that stenting is reserved for selected situations. Understanding why — and what the procedure involves when it is chosen — can help you have a more confident conversation with your doctors.

What Is Intracranial Arterial Stenting?

Intracranial arterial stenting is a minimally invasive, catheter-based procedure used to widen a severely narrowed artery inside the brain. It is performed by an interventional neuroradiologist or neurointerventional specialist, working entirely from inside the blood vessels without opening the skull or cutting into brain tissue.

The narrowing is most often caused by intracranial atherosclerotic disease (ICAD), in which fatty plaque builds up on the inner wall of a brain artery over many years. Less commonly, narrowing can result from inflammation of the artery wall, a previous tear (dissection), or other vascular conditions. Whatever the cause, the result is the same: less blood reaches the brain tissue that the artery supplies, and the risk of a stroke from a blood clot forming at the narrowed segment rises.

What a Stent Is and What It Does

A stent is a small tube made of a fine metal mesh. It is mounted in a collapsed form on a thin catheter, guided into position inside the narrowed artery, and then expanded so that it presses outward against the artery wall. Once in place, the stent acts as a scaffold — holding the artery open and allowing blood to flow through more freely.

Stents designed for the brain’s arteries are different from those used in the heart or in larger arteries elsewhere in the body. Brain arteries are smaller, more delicate, and follow curving paths through bone and brain tissue. The stents are usually self-expanding (they spring open when released) and are made of materials chosen for flexibility and biocompatibility.

How It Differs from Other Brain Procedures

Intracranial arterial stenting is not brain surgery in the traditional sense. There is no scalp incision, no opening of the skull, and no direct handling of brain tissue. The entire procedure is performed through a small puncture in an artery in the wrist (the radial artery) or the groin (the femoral artery). It also differs from carotid stenting, which treats narrowing of the larger carotid arteries in the neck before they enter the skull. Intracranial stenting works on the smaller, more fragile arteries inside the skull itself, which makes it technically more demanding.

Why Intracranial Arterial Stenting Is Performed

The goal of intracranial arterial stenting is to reduce the risk of a future stroke in patients whose risk is unusually high despite other treatments. It is not used to reverse damage from a stroke that has already happened, and it is not a routine treatment for everyone with brain artery narrowing.

The Underlying Problem It Addresses

When a brain artery is severely narrowed, two main mechanisms can cause a stroke. First, blood may flow so slowly through the narrowing that downstream brain tissue does not receive enough oxygen, particularly during periods of low blood pressure. Second, the rough surface of the narrowing can trigger blood clots that travel forward and block smaller branches. Both mechanisms can produce a transient ischemic attack (TIA, sometimes called a mini-stroke) or a full ischemic stroke.

By widening the artery and creating a smoother inner channel, a stent aims to improve blood flow and reduce the chance of clot formation at that site.

Common Indications

Stenting is generally considered in patients who have:

• Severe narrowing of an intracranial artery, typically 70% or more
• Symptoms clearly linked to that artery — such as TIAs or a recent stroke in the territory it supplies
• Recurrent symptoms despite optimal medical therapy, meaning the patient has continued to have TIAs or strokes even while taking the full recommended combination of medications and managing risk factors
• Narrowing of major arteries such as the middle cerebral artery, the basilar artery, the vertebral artery within the skull, or parts of the internal carotid artery inside the skull

Patients without symptoms, or those whose narrowing is less severe, are usually not candidates. The American Heart Association and American Stroke Association (AHA/ASA) emphasise that intensive medical therapy is the first-line treatment, and that stenting is reserved for carefully selected patients in whom medical therapy has failed.

Who Is a Candidate?

Selection for intracranial arterial stenting involves more than just measuring how narrow the artery is. The interventional team considers the whole clinical picture, the location of the narrowing, the patient’s response to medications, and the technical feasibility of reaching the lesion safely.

Factors That Support Candidacy

• A clear pattern of symptoms attributable to the narrowed artery
• Failure of dual antiplatelet therapy and aggressive risk factor control to prevent further events
• An artery and lesion shape that can be reached safely with current devices
• A patient who is medically fit enough to tolerate the procedure and to take antiplatelet medications afterward
• Realistic understanding of both the potential benefit and the procedure’s risks

Factors That May Argue Against the Procedure

• Asymptomatic narrowing, even if severe
• Very recent stroke with a large area of damaged brain, which can increase procedural risk
• Severe bleeding tendency or inability to take antiplatelet medications
• Anatomy that makes the artery difficult or unsafe to reach with a catheter
• Other serious health problems that would limit overall benefit

The decision is usually made by a multidisciplinary team that includes a stroke neurologist and the interventional neuroradiologist, sometimes with input from a vascular neurosurgeon. The discussion includes a careful review of imaging, the medications already tried, and the patient’s own preferences.

Alternatives to Consider

One of the most important parts of understanding intracranial arterial stenting is understanding what comes before it — and what is offered instead for most patients. Treatment of intracranial arterial narrowing has shifted significantly over the past decade, and the central message from major stroke societies is that medical therapy is the foundation.

Intensive Medical Therapy

The current first-line approach recommended by the AHA/ASA for patients with symptomatic intracranial atherosclerotic disease is intensive medical therapy. This typically includes:

• Dual antiplatelet therapy — usually aspirin combined with clopidogrel for a defined period (often around 90 days), followed by single antiplatelet therapy long term
• High-intensity statin therapy — to lower LDL cholesterol substantially and stabilise plaque
• Aggressive blood pressure control — with specific targets set by the treating doctor
• Tight diabetes control if diabetes is present
• Smoking cessation
• Structured lifestyle change — including a Mediterranean-style diet, regular physical activity, and weight management

The reason this is the default approach is evidence from the SAMMPRIS trial (Stenting versus Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis), which found that intensive medical therapy alone produced better outcomes than stenting plus medical therapy in the general population of patients studied. This finding has shaped guidelines worldwide. For the subset of patients who continue to have symptoms despite this intensive approach, stenting becomes a consideration — but only after the medical approach has been given a fair trial.

Angioplasty Alone

In some cases, the interventional team may consider balloon angioplasty without stent placement — gently widening the artery with a small balloon and leaving no implant behind. This may be appropriate for certain lesion types or when stent delivery is anatomically difficult.

Bypass Surgery

Extracranial-to-intracranial (EC-IC) bypass surgery, in which a scalp artery is connected to a brain artery to route blood around a blocked segment, is used in highly selected cases — particularly in patients with documented poor blood flow reserve. It is a major neurosurgical procedure and is not appropriate for most patients with intracranial stenosis.

Continued Medical Management Alone

For many patients, particularly those without continuing symptoms on full medical therapy, ongoing medical management remains the long-term plan. Stenting is considered when symptoms persist despite this approach.

How the Procedure Is Performed

Intracranial arterial stenting is performed in a specialised room called an angiography suite or neurointerventional suite. The room is equipped with a high-resolution X-ray system (a biplane angiography unit) that allows the team to see the brain’s arteries in real time from two angles at once.

Anaesthesia and Monitoring

The procedure may be performed under general anaesthesia (you are fully asleep) or under conscious sedation with local anaesthesia at the access site. The choice depends on the case complexity, the centre’s practice, and patient factors. Throughout the procedure, your heart rhythm, blood pressure, oxygen levels, and (when awake) your neurological status are continuously monitored.

Step-by-Step Walkthrough

1. Access. A small puncture is made in the femoral artery (groin) or the radial artery (wrist). A thin tube called a sheath is placed in the artery to provide a working channel.
2. Catheter navigation. Under continuous X-ray guidance, a catheter is advanced from the access point, up through the aorta, and into the arteries that supply the brain.
3. Diagnostic angiography. Contrast dye is injected through the catheter to produce detailed images of the brain’s arteries. This confirms the location, length, and severity of the narrowing.
4. Lesion crossing. A very fine guidewire is carefully passed across the narrowed segment. This is one of the most delicate steps in the procedure.
5. Balloon angioplasty (if used). A small balloon is advanced over the wire and gently inflated to open the narrowing and prepare it for the stent.
6. Stent deployment. The stent, mounted in a collapsed form on its delivery system, is positioned across the narrowing and released so that it expands against the artery wall.
7. Confirmation. A second round of angiography confirms that the stent is well-positioned, the artery is open, and blood is flowing well.
8. Closure. The catheters and sheath are removed. The access site is closed by manual pressure, a small closure device, or a stitch.

The procedure typically takes one to three hours from start to finish, though more complex cases can take longer. The brain’s arteries are small and follow curving paths, so the work requires steady, precise movement and continuous imaging guidance.

Preparing for the Procedure

Preparation for intracranial arterial stenting usually begins several days to weeks before the procedure date. Good preparation is one of the most important factors in a smooth experience and a good outcome.

Tests and Assessments

Before the procedure, your team will usually arrange:

• Detailed brain imaging — an MRI or CT scan of the brain to assess any prior stroke damage and the current state of the brain tissue
• Vessel imaging — CT angiography (CTA), MR angiography (MRA), or digital subtraction angiography (DSA) to map the narrowed artery and the surrounding circulation
• Blood tests — including a complete blood count, kidney function tests, and clotting studies
• Cardiac assessment — an ECG and sometimes an echocardiogram, particularly in older patients or those with heart conditions
• Anaesthesia consultation if general anaesthesia is planned

Medications Before the Procedure

Most patients are started on dual antiplatelet therapy — usually aspirin and clopidogrel — for at least several days before the procedure. These medications help prevent clots from forming on the new stent. In some centres, a blood test is used to confirm that clopidogrel is working effectively in the individual patient; if the test shows poor response, an alternative drug may be chosen.

Your doctor will also review all your current medications and tell you which to continue, pause, or adjust. Blood thinners other than antiplatelets, certain diabetes medications, and some supplements may need to be stopped temporarily.

Practical Preparation

• You will usually be asked to stop eating several hours before the procedure
• Arrange for someone to accompany you to and from the hospital
• Bring a list of your current medications, allergies, and prior imaging if available
• Wear loose, comfortable clothing and leave valuables at home

What to Expect During and Immediately After

During the Procedure

If you are awake during the procedure, you may feel some pressure at the access site when the sheath is placed, but no pain inside the brain itself &mdash — brain tissue has no pain receptors. You may feel a warm sensation when contrast dye is injected. The team will often check in with you by asking you to move your arms or legs and to speak, to monitor your neurological status in real time.

If you have general anaesthesia, you will not be aware of the procedure and will wake up afterward in a recovery area.

Immediately After

You will be transferred to an intensive care unit (ICU), a stroke unit, or a high-dependency unit for close monitoring during the first 24 to 48 hours. The team watches for any neurological changes, monitors your blood pressure carefully (tight blood pressure control after the procedure is very important), and checks the access site for bleeding or swelling.

If the femoral artery was used, you will usually need to keep that leg straight for several hours to prevent bleeding. If the radial artery was used, a small wrist band applies gentle pressure for a few hours, and you can usually move around sooner.

Recovery and Healing

In Hospital

Most patients stay in hospital for two to four days. The first 24 to 48 hours are spent in a monitored unit. Once your team is satisfied that the artery is stable, blood pressure is controlled, and there are no complications, you move to a regular ward and then home.

The First Few Weeks at Home

• Mild discomfort or bruising at the access site is common and usually settles within one to two weeks
• Some patients have mild headaches in the first days after the procedure
• You will be asked to avoid heavy lifting, strenuous activity, and driving for a period defined by your team
• Walking and light activity are usually encouraged early to support circulation
• Strict adherence to dual antiplatelet therapy is critical — missing doses raises the risk of stent clotting

Returning to Normal Activities

Most people return to light daily activities within one to two weeks. Return to work depends on the nature of the work; office-based work may be possible within a couple of weeks, while physically demanding work may require longer. Your team will give specific guidance based on your case.

Driving usually resumes only after a clinical review, particularly if you had stroke symptoms before the procedure that affected vision, attention, or movement.

Risks and Complications

Intracranial arterial stenting is a delicate procedure in a highly sensitive part of the body. The brain’s arteries are smaller and more fragile than arteries elsewhere, and the consequences of complications can be significant. An honest understanding of the risks is part of an informed decision.

Procedural Risks

• Stroke during or shortly after the procedure. This is the most important risk. It can occur if a blood clot forms on the equipment, if a small piece of plaque breaks loose, or if a small branch artery is blocked. The SAMMPRIS trial highlighted that early peri-procedural stroke risk is a major reason stenting is reserved for selected patients.
• Bleeding inside the brain. Less common, but serious. It can result from artery injury or from sudden changes in blood flow to a region that had been receiving very little blood.
• Artery injury or dissection. A tear in the artery wall caused by the wire or balloon. This can sometimes be treated during the same procedure.
• Stent thrombosis. A blood clot forming on the stent itself. This is why dual antiplatelet therapy is critical in the months after the procedure.

Access Site Risks

• Bruising, bleeding, or hematoma at the groin or wrist
• Less commonly, injury to the artery used for access, sometimes requiring repair

Contrast and Anaesthesia Risks

• Allergic reactions to contrast dye, ranging from mild to severe
• Temporary stress on kidney function, particularly in patients with pre-existing kidney problems
• Standard risks of anaesthesia if general anaesthesia is used

Later Complications

• Restenosis. Re-narrowing of the artery at the stent site, which can occur in the months after the procedure. Follow-up imaging is used to detect this.
• Bleeding from antiplatelet medications. Long-term antiplatelet therapy slightly increases the risk of bleeding, particularly in the digestive tract.

Your team will discuss the specific risk profile for your case, which depends on the location of the narrowing, your overall health, and centre experience. Outcomes are best in high-volume centres with experienced operators.

Life After Intracranial Arterial Stenting

Stenting is one part of a longer-term plan to protect the brain from future strokes. The procedure addresses the narrowed segment, but it does not change the underlying disease process that caused the narrowing in the first place. That process — usually atherosclerosis — continues to affect other arteries throughout the body, and managing it remains a lifelong project.

Medications

After the procedure, you will typically take:

• Dual antiplatelet therapy for a defined period (often around 3 months, sometimes longer), followed by single antiplatelet therapy long term
• A high-intensity statin to lower cholesterol and stabilise plaque elsewhere in the body
• Blood pressure medications as needed to meet target levels
• Diabetes medications if applicable

It is very important not to stop antiplatelet medications without discussing it with your doctor. Stopping early — even for a planned dental or surgical procedure — can increase the risk of stent clotting and stroke. If another procedure is planned, your team will work with the other doctors to manage the timing of medications safely.

Risk Factor Control

Long-term outcomes depend heavily on how well the underlying risk factors are managed. This includes:

• Keeping blood pressure within the target range set by your doctor
• Keeping LDL cholesterol low, often well below standard population targets
• Tight diabetes control if diabetes is present
• Complete avoidance of smoking, including passive smoke
• Regular physical activity, adapted to your abilities
• A diet emphasising vegetables, fruits, whole grains, fish, and healthy fats; limiting processed foods, salt, and added sugars
• Healthy sleep, stress management, and weight in a healthy range

Follow-Up Imaging and Visits

You will have follow-up visits with the stroke neurologist and the interventional team. Imaging — usually CT angiography, MR angiography, or in some cases catheter angiography — is used to check the stent and the artery at intervals defined by your team. New or recurring symptoms should always trigger prompt review.

Recognising Warning Signs of Stroke

• F — Face drooping. Does one side of the face droop or feel numb? Ask the person to smile.
• A — Arm weakness. Is one arm weak or numb? Ask the person to raise both arms.
• S — Speech difficulty. Is speech slurred, hard to understand, or is the person unable to speak?
• T — Time to call emergency services. If any of these signs are present, even if they go away, treat it as an emergency.

Other sudden symptoms that warrant immediate evaluation include sudden severe headache unlike any before, sudden vision loss, sudden severe dizziness or loss of balance, and sudden confusion.

Frequently Asked Questions

Is intracranial arterial stenting the same as a heart stent?

No. Both use a metal mesh tube to keep an artery open, but the arteries are very different. Brain arteries are smaller, more fragile, and surrounded by sensitive brain tissue. The stents, the techniques, and the operator training are specific to neurointerventional work.

Why do guidelines favour medical therapy as the first treatment?

A large clinical trial (SAMMPRIS) found that for most patients with symptomatic intracranial arterial narrowing, intensive medical therapy produced better outcomes than adding a stent. As a result, the AHA/ASA recommends intensive medical therapy as the first-line approach. Stenting is considered in selected patients whose symptoms continue despite this therapy.

What does “failure of medical therapy” actually mean?

It usually means that a patient has continued to have TIAs or strokes in the territory of the narrowed artery while taking the full recommended combination of antiplatelet medications and with risk factors well-controlled. The treating team makes this judgment based on the clinical pattern and imaging.

How long do I need to stay on dual antiplatelet therapy after the procedure?

The duration is decided by your treatment team and depends on your specific case. A common pattern is several months of dual antiplatelet therapy followed by single antiplatelet therapy long term, but the plan should be individualised.

Can the stented artery narrow again?

Yes. Re-narrowing at the stent site (restenosis) can occur in the months after the procedure. This is why follow-up imaging is part of routine care. If restenosis is detected, the team will discuss the best response, which may include continued monitoring, medication adjustment, or in some cases another procedure.

Does stenting reverse the damage from a previous stroke?

No. Stenting is intended to lower the risk of a future stroke by improving blood flow through the narrowed segment. Recovery from a previous stroke depends on rehabilitation and the brain’s own healing processes, not on stenting.

Will I be able to feel the stent?

No. The stent is a very small, lightweight implant deep inside an artery and is not felt from outside.

Can I have MRI scans after a stent is placed?

Most modern neurovascular stents are MRI-conditional, meaning MRI scans can be done safely under defined conditions. You will be given an implant card with the stent details; share this with any team performing an MRI in the future.

What lifestyle changes matter most after the procedure?

Not smoking, controlling blood pressure, keeping LDL cholesterol low, managing diabetes if present, regular physical activity, and a heart-healthy diet are the most influential factors. These are the same factors that drive the long-term outcome of the underlying arterial disease.

Conclusion

Intracranial arterial stenting is a specialised tool for a specific problem: severe narrowing of a brain artery in a patient who continues to have symptoms despite intensive medical therapy. It is not the first treatment for intracranial arterial disease, and it is not appropriate for everyone with narrowed brain arteries. For carefully selected patients, performed in experienced centres, it can be one part of a strategy to lower stroke risk.

The decision to proceed is best made with a stroke neurologist and an interventional neuroradiologist who can review your imaging, your medication history, and your overall picture together. Whether stenting is part of your plan or not, the foundation of long-term protection against stroke remains the same — consistent medications, well-managed risk factors, and steady follow-up over time.